Production of Recombinant Gelonin Using an Automated Liquid Chromatography System

Advances in recombinant DNA technology have opened up new possibilities of exploiting toxic proteins for therapeutic purposes. Bringing forth these protein toxins from the bench to the bedside strongly depends on the availability of production methods that are reproducible, scalable and comply with...

Descripción completa

Detalles Bibliográficos
Autores principales: Berstad, Maria E. B., Cheung, Lawrence H., Weyergang, Anette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472732/
https://www.ncbi.nlm.nih.gov/pubmed/32823678
http://dx.doi.org/10.3390/toxins12080519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472732/
https://www.ncbi.nlm.nih.gov/pubmed/32823678
http://dx.doi.org/10.3390/toxins12080519

Ejemplares similares